Maternal Substance Use During Pregnancy and Congenital Syphilis Among Hospitalized Neonates
Public Health Reports® · 20.11.2026
DOI: 10.1177/00333549261497292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Reports®, online erschienen am 20.11.2026. Verfasst von Amy Koid und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Objectives
US congenital syphilis (CS) cases have increased 10-fold in the past decade, exceeding 3700 cases in 2022. This study evaluated the association between maternal substance use during pregnancy and CS among hospitalized neonates by region and year.
Methods
We analyzed hospitalized neonates (postnatal age ≤28 days) in the Kids’ Inpatient Database from 2016, 2019, and 2022. We identified CS using International Classification of Diseases, Tenth Revision codes and categorized maternal substance use as no substance use, single substance use, or polysubstance use. Using survey-weighted multivariable logistic regression, we tested effect modification by region and year.
Results
Among 4 531 346 hospitalized neonates, 217 220 (weighted prevalence = 2.5%) had maternal substance use during pregnancy. CS prevalence among substance-exposed neonates increased 467% from 2.5 to 14.5 per 1000 neonates between 2016 and 2022, compared with 0.2 to 0.8 per 1000 neonates among unexposed neonates. After adjusting for demographic charateristics, health insurance status, median household income, housing insecurity, year, and region, single substance use and polysubstance use were associated with higher odds of CS (single substance use: adjusted odds ratio [AOR] = 9.68; 95% CI, 8.88-10.55; and polysubstance use: AOR = 17.18; 95% CI, 15.21-19.40). We observed a significant effect modification: the association was much stronger in the West region of the United States (interaction OR = 4.80; 95% CI, 3.10-7.44) than in the Northeast, and the polysubstance use association was significantly elevated in 2022 relative to 2016 (interaction OR = 3.10; 95% CI, 1.81-5.30).
Conclusions
Maternal substance use was strongly associated with CS. These findings underscore the need to address structural barriers to prenatal care through the expansion and integration of syphilis screening within substance use treatment and harm-reduction contexts, especially in regions with a high burden of CS.
Zitieren
APA
Koid, A., Shamseldin, H., Leir, S., & Joo, S. J. (2026). Maternal Substance Use During Pregnancy and Congenital Syphilis Among Hospitalized Neonates. Public Health Reports®. https://doi.org/10.1177/00333549261497292
Vancouver
Koid A, Shamseldin H, Leir S, Joo SJ. Maternal Substance Use During Pregnancy and Congenital Syphilis Among Hospitalized Neonates. Public Health Reports®. 2026. doi:10.1177/00333549261497292
BibTeX
@article{Koid2026,
author = {Koid, Amy and Shamseldin, Hebatalla and Leir, Sarah and Joo, Su Jin},
title = {Maternal Substance Use During Pregnancy and Congenital Syphilis Among Hospitalized Neonates},
journal = {Public Health Reports®},
year = {2026},
doi = {10.1177/00333549261497292}
}
EUVIMED